A novel compound 3-{5- (azetidin-1- ylcarbonyl)pyrazin-2- yloxy}-5-{(1S)-1-methyl-2- (methyloxy)ethyloxy}- N-(5-methylpyrazin-2- yl)benzamide

摘要

pCompounds of formula (I) wherein RSUP1/SUP, HET-1 and HET-2 are as described in the specification, and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described./p[WO2007007041A1]